The Integration of Artificial Intelligence and Personalized Dosimetry in the Radiopharmaceutical Market
In the realm of nuclear medicine, delivering a lethal dose of radiation to a tumor while sparing healthy organs is a delicate balancing act. Historically, radioligand therapies have been administered using a standardized, "one-size-fits-all" dosing approach based on a patient's body weight or surface area. However, as the Radiopharmaceutical Market matures, the industry is rapidly pivoting...
0 Comentários 0 Compartilhamentos 104 Visualizações 0 Anterior